Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy. (Q40287396)
scientific article published on May 2006
Language:
(P31) (Q13442814)
(P50) (Q42702450)
(P304) 355-364
(P433) 5
(P478) 63
(P577) Monday, May 1, 2006
(P921) (Q172341)
(Q1427096)
(P1433) (Q15762682)
(P1476) "Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy" (language: en)
(P2093) Bjørge L
Stoiber H
Dierich MP
(P2860) (Q33774245)
(Q40737575)
(Q28210663)
(Q36646213)
(Q55475633)
(Q33537711)
(Q41314826)
(Q33678970)
(Q32030747)
(Q41642431)
(Q33743260)
(Q34322325)
(Q41135107)
(Q36431698)
(Q33852679)
(Q35753353)
(Q42104717)
(Q53966785)
(Q47815717)
(Q53942590)
(Q74292297)
(Q68583238)
(Q78167029)
(Q40875124)
(Q78785334)
(Q79275806)
(Q74147920)
other details
description scientific article published on May 2006

External Links